BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 7477939)

  • 21. The role of the globus pallidus D2 subfamily of dopamine receptors in pallidal immediate early gene expression.
    Marshall JF; Henry BL; Billings LM; Hoover BR
    Neuroscience; 2001; 105(2):365-78. PubMed ID: 11672604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentiation of D2-dopamine receptor-mediated suppression of zif 268 by non-competitive NMDA receptor antagonists in reserpinized rats.
    Leslie CA; Jung A; Bennett JP
    Brain Res Mol Brain Res; 1998 Aug; 59(1):40-9. PubMed ID: 9729266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclic 3',5'-adenosine monophosphate mediates dopamine D1-stimulated growth hormone release from goldfish pituitary cells.
    Wong AO; van der Kraak G; Chang JP
    Neuroendocrinology; 1994 Oct; 60(4):410-7. PubMed ID: 7529899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reserpine increases Fos activity in the rat basal ganglia via a quinpirole-sensitive mechanism.
    Cole DG; Di Figlia M
    Neuroscience; 1994 May; 60(1):115-23. PubMed ID: 7914358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of NGFI-A mRNA in the rat striatum following burst stimulation of the medial forebrain bundle.
    Chergui K; Svenningsson P; Nomikos GG; Gonon F; Fredholm BB; Svennson TH
    Eur J Neurosci; 1997 Nov; 9(11):2370-82. PubMed ID: 9464931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum.
    Doucet JP; Nakabeppu Y; Bedard PJ; Hope BT; Nestler EJ; Jasmin BJ; Chen JS; Iadarola MJ; St-Jean M; Wigle N; Blanchet P; Grondin R; Robertson GS
    Eur J Neurosci; 1996 Feb; 8(2):365-81. PubMed ID: 8714707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enkephalin regulates acute D2 dopamine receptor antagonist-induced immediate-early gene expression in striatal neurons.
    Steiner H; Gerfen CR
    Neuroscience; 1999; 88(3):795-810. PubMed ID: 10363818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. D1 priming enhances both D1- and D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats.
    Pollack AE; Thomas LI
    Pharmacol Biochem Behav; 2010 Jan; 94(3):346-51. PubMed ID: 19800912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D; Osborn CV
    Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiological verification of the presence of D1 and D2 dopamine receptors within the ventral pallidum.
    Napier TC; Maslowski-Cobuzzi RJ
    Synapse; 1994 Jul; 17(3):160-6. PubMed ID: 7974198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenosine antagonists potentiate D2 dopamine-dependent activation of Fos in the striatopallidal pathway.
    Pollack AE; Fink JS
    Neuroscience; 1995 Oct; 68(3):721-8. PubMed ID: 8577368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of immediate early genes by cyclic AMP in primary cultures of neurons from rat cerebral cortex.
    Vaccarino FM; Hayward MD; Le HN; Hartigan DJ; Duman RS; Nestler EJ
    Brain Res Mol Brain Res; 1993 Jul; 19(1-2):76-82. PubMed ID: 8103187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum.
    Chen JF; Aloyo VJ; Weiss B
    Neuroscience; 1993 Jun; 54(3):669-80. PubMed ID: 8101360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compartmentally specific effects of quinpirole on the striatal Fos expression induced by stimulation of D1-dopamine receptors in intact rats.
    Wirtshafter D; Schardt G; Asin KE
    Brain Res; 1997 Oct; 771(2):271-7. PubMed ID: 9401747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Examination of the involvement of protein kinase A in D2 dopamine receptor antagonist-induced immediate early gene expression.
    Adams AC; Keefe KA
    J Neurochem; 2001 Apr; 77(1):326-35. PubMed ID: 11279288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AMP-activated protein kinase slows D2 dopamine autoreceptor desensitization in substantia nigra neurons.
    Yang W; Munhall AC; Johnson SW
    Neuropharmacology; 2019 Nov; 158():107705. PubMed ID: 31301335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT; Brooderson RJ; White FJ
    Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression of proenkephalin and prodynorphin genes and the induction of c-fos gene by dopaminergic drugs are not altered in the straitum of MPTP-treated mice.
    Ziolkowska B; Horn G; Kupsch A; Höllt V
    J Neural Transm Park Dis Dement Sect; 1995; 9(2-3):151-64. PubMed ID: 8527000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Turgeon SM; Fink JS
    Neuroscience; 1997 Jul; 79(1):79-93. PubMed ID: 9178866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenosine A2 receptors stimulate c-fos expression in striatal neurons of 6-hydroxydopamine-lesioned rats.
    Morelli M; Pinna A; Wardas J; Di Chiara G
    Neuroscience; 1995 Jul; 67(1):49-55. PubMed ID: 7477908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.